Invention Publication
- Patent Title: COMPOSITION COMPRISING PIP4K2C INHIBITOR AS ACTIVE INGREDIENT FOR TREATMENT OF CANCER
-
Application No.: US18676998Application Date: 2024-05-29
-
Publication No.: US20240316066A1Publication Date: 2024-09-26
- Inventor: Darren WILLIAMS , Hyunju LEE , Da-Woon JUNG , Eun-Mi JANG , Jihee SOH
- Applicant: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Gwangju
- Assignee: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: KR Gwangju
- Priority: KR 20210168747 2021.11.30
- Main IPC: A61K31/58
- IPC: A61K31/58 ; A61K31/192 ; A61K31/47 ; A61K31/506 ; A61K31/5375 ; A61K45/06 ; A61P35/00 ; C12Q1/6886 ; G01N33/50
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating cancer comprising a PIP4K2C inhibitor as an active ingredient. The present invention provides a composition for efficient and radical treatment of cancer by discovering PIP4K2C as a new treatment target for cancer, which exhibits a high recurrence rate and is difficult to radically treat, and selecting a drug that inhibits PIP4K2C among known anticancer drugs.
Information query
